Visión Digna promotes retinography for early diabetic eye damage detection

Visión Digna launched an initiative in Mexico City aimed at internists, endocrinologists and general practitioners to refer patients with diabetes, hypertension and metabolic syndrome for preventive retinography. The effort seeks earlier detection of retinal damage before vision loss becomes noticeable.

Why it matters: - Retinography can identify retinal damage before a diabetic patient notices vision loss. - Earlier detection may speed referral to retina specialists and reduce the risk of preventable vision loss. - The initiative also gives primary and metabolic care doctors a faster screening path for patients with vascular risk.

What happened: - Visión Digna announced an outreach effort for internists, endocrinologists, general practitioners and first-contact clinicians. - The campaign focuses on patients with diabetes mellitus, hypertension and metabolic syndrome. - The goal is to drive early referrals for retinography as a preventive retinal screening tool. - The announcement was made in Miguel Hidalgo, Mexico City, on July 1, 2026.

The details: - Retinography is positioned as a quick, accessible test for documenting the condition of the retina in patients with diabetes, hypertension or vascular risk. - The test is not meant to replace an ophthalmologist’s evaluation. - The test is meant to help identify suspicious findings and trigger timely specialist referral. - Retinography can show signs compatible with diabetic retinopathy, hypertensive retinopathy, vascular changes, optic nerve changes, macular lesions and other relevant findings. - In diabetic patients, those results can help determine whether the next step should be observation, close follow-up, OCT macular imaging, angiography, laser treatment, intravitreal therapy or urgent retina evaluation. - Visión Digna said the approach can fit into clinics, practices and metabolic-control programs that want a more organized vision-prevention pathway. - Patients can be sent directly to retinography, then routed to follow-up, full ophthalmology evaluation or retina specialty care based on the findings. - The organization also says the model can document changes linked to hypertension, chronic vascular damage, suspected macular edema, hemorrhages, exudates and optic nerve abnormalities. - Visión Digna is an ophthalmology center focused on diagnostic studies, preventive eye care and specialized treatment in retina, glaucoma, cataract and eye disease associated with diabetes and hypertension. - The center’s model includes retinography, OCT macular imaging, OCT of the optic nerve, visual fields and specialized ophthalmology evaluation.

Between the lines: - The campaign is aimed at shifting eye screening earlier in the care chain, before patients reach an eye doctor with symptoms. - The message also expands retinal screening from an ophthalmology issue into part of routine metabolic and cardiovascular risk management. - That framing could make referral easier for non-eye specialists who already see these patients regularly.

What's next: - Visión Digna is asking medical professionals to make retinography a more routine request for patients with diabetes, hypertension or metabolic syndrome. - The center is also directing interested clinicians and patients to its official website for more information on retinography and diabetic retinopathy detection. - Dr. José Francisco Valdez López, founder of Visión Digna, said the effort is meant to help doctors refer patients before visual symptoms appear.